iScreen Vision is a biotechnology and healthcare startup based in the United States. Founded in 2009, the company focuses on detecting early vision damage risk in children through instrument-based vision screening technology and specialized analysis. Traditional vision screening methods can be costly and potentially damaging to pediatric patients' long-term vision health. The company's digital vision screening technology offers a highly sensitive, specific, and accurate screening process. Each image is meticulously reviewed by a certified ophthalmic professional using sophisticated algorithms and their experience to catch any irregularities that software alone may miss. iScreen Vision offers easy integration of their technology with minimal upfront investment and provides training and support for efficient operation. The company received a $110.00K Debt Financing investment on July 8, 2016, from Innova Memphis. With a slogan of "Detect Early Vision Damage Risk in Children", iScreen Vision aims to offer enhanced vision care for pediatric patients while helping healthcare practices generate revenue.
There is no investment information
No recent news or press coverage available for iScreen Vision.